Shares of UWM Are Plummeting - Will This Trend Continue?

This afternoon we watched UWM drop -4.0% to a price of $5.58 per share. The small-cap Diversified Financial company is now trading -5.35% below its average target price of $5.89. Analysts have set target prices ranging from $4.0 to $8.0 per share for UWM, and have given the stock an average rating of hold.

The stock has an unusually large proportion of its shares sold short at 20.1%, and a short ratio of 16.7. The company's insiders own 4.44% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that only a small number of institutional investors are invested in the stock, with 43.5% of UWM's shares being owned by this investor type.

Institutions Invested in UWM

Date Reported Holder Percentage Shares Value
2023-06-30 Vanguard Group Inc 9% 8,814,389 $49,140,216
2023-06-30 Platinum Equity, LLC 5% 4,894,101 $27,284,612
2023-06-30 FMR, LLC 5% 4,652,633 $25,938,428
2023-06-30 Blackrock Inc. 4% 4,055,711 $22,610,588
2023-06-30 Northern Trust Corporation 2% 1,909,310 $10,644,402
2023-06-30 Victory Capital Management Inc. 2% 1,722,346 $9,602,078
2023-06-30 State Street Corporation 2% 1,412,917 $7,877,012
2023-06-30 Geode Capital Management, LLC 1% 1,322,266 $7,371,632
2023-06-30 Renaissance Technologies, LLC 1% 1,304,980 $7,275,263
2023-06-30 Bank Of New York Mellon Corporation 1% 832,135 $4,639,152

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on UWM.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS